TNFSF10
Tumor necrosis factor ligand superfamily member 10
Also known as: Apo-2L, CD253, TL2, TNF10_HUMAN, TRAIL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50591
- Gene
- TNFSF10
- Ensembl
- ENSG00000121858
- Chromosome
- 3
- Canonical length
- 281 aa
- Protein class
- Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
281 residues, UniProt reviewed canonical sequence.
>P50591|TNFSF10
1 MAMMEVQGGP SLGQTCVLIV IFTVLLQSLC VAVTYVYFTN ELKQMQDKYS KSGIACFLKE
61 DDSYWDPNDE ESMNSPCWQV KWQLRQLVRK MILRTSEETI STVQEKQQNI SPLVRERGPQ
121 RVAAHITGTR GRSNTLSSPN SKNEKALGRK INSWESSRSG HSFLSNLHLR NGELVIHEKG
181 FYYIYSQTYF RFQEEIKENT KNDKQMVQYI YKYTSYPDPI LLMKSARNSC WSKDAEYGLY
241 SIYQGGIFEL KENDRIFVSV TNEHLIDMDH EASFFGAFLV GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFSF10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 195 nTPM
Expression across tissuesHPA
Tissue
- liver: 195 nTPM
- lung: 167 nTPM
- placenta: 158 nTPM
- kidney: 135 nTPM
- salivary gland: 129 nTPM
- duodenum: 94 nTPM
Single-cell type
- esophageal apical cells: 805 nCPM
- prostatic hillock cells: 438 nCPM
- respiratory secretory cells: 400 nCPM
- prostatic club cells: 399 nCPM
- neutrophils: 397 nCPM
- extravillous trophoblasts: 372 nCPM
Immune cell
- basophil: 266 nTPM
- neutrophil: 258 nTPM
- non-classical monocyte: 214 nTPM
- intermediate monocyte: 204 nTPM
- classical monocyte: 134 nTPM
- total PBMC: 74 nTPM
Brain region
- choroid plexus: 25 nTPM
- medulla oblongata: 13 nTPM
- pons: 11 nTPM
- spinal cord: 11 nTPM
- thalamus: 9.6 nTPM
- white matter: 9.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell surface receptor signaling pathway
- cell-cell signaling
- immune response
- positive regulation of apoptotic process
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of extrinsic apoptotic signaling pathway
- positive regulation of release of cytochrome c from mitochondria
- signal transduction
- TRAIL-activated apoptotic signaling pathway
Molecular functions
- cytokine activity
- identical protein binding
- signaling receptor binding
- TRAIL binding
- tumor necrosis factor receptor binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFSF10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFSF10 as an antibody target. Whether an autoantibody or antibody against TNFSF10 could matter depends on whether native TNFSF10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFSF10 is annotated at the cell surface, where native TNFSF10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFSF10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...